Share class: Shenzhen YHLO Biotech Co., Ltd.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 571,388,300 262,740,876 ( 45.98 %) 0 45.98 %

Major shareholders: Shenzhen YHLO Biotech Co., Ltd.

NameEquities%Valuation
44.1 %
251,500,100 44.1 % 508 M ¥
Ningbo Pengrui Enterprise Management Partnership LP
2.823 %
16,101,467 2.823 % 33 M ¥
Shenzhen Yingfu Huizhi Private Equity Fund Co. Ltd.
2.672 %
15,239,087 2.672 % 31 M ¥
Jiaxing Ruiyao Equity Investment LP
2.241 %
12,780,804 2.241 % 26 M ¥
Hwabao WP Fund Management Co., Ltd.
2.002 %
11,418,521 2.002 % 23 M ¥
Hainan Shuofeng Private Equity Fund Management Pp LP
1.972 %
11,247,147 1.972 % 23 M ¥
Ningbo Junhui Enterprise Management Partnership LP
1.736 %
9,898,000 1.736 % 20 M ¥
China Merchants Fund Management Co., Ltd.
1.424 %
8,119,149 1.424 % 16 M ¥
1.176 %
6,706,400 1.176 % 14 M ¥
LAV Management Co., Ltd.
1.062 %
6,054,869 1.062 % 12 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Individuals45.28%
Other11.44%
Institutional8.26%
Unknown35.02%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
45.28%
China
19.71%

Based on 1000 largest holdings

Logo Shenzhen YHLO Biotech Co., Ltd.
Shenzhen YHLO Biotech Co Ltd is a China-based company primarily engaged in the provision of in vitro diagnostic instruments. The Company mainly focuses on the research, development, production, and sales of in vitro diagnostic instruments and related reagents based on chemiluminescence immunoassay, as well as the agency sales of some non-self-produced medical device products. The Company's products are used in fields such as autoimmunity, reproductive health, diabetes, and infectious diseases. The Company's products are sold in domestic and international markets.
Employees
1,678